Demant A/S : Hello Hello!!! – What for a performance!
>Q1 preliminary numbers a strong beat - Demant’s preliminary Q1 revenues of DKK 5,508m (+19.7% y-o-y) were driven by an impressive organic growth of 14% (vs ODDO BHF 7.9%/ consensus 3.0%) and were a beat of 12% of the consensus and 8% ahead of our forecast. No bottom line was reported on a preliminary base. Stellar hearing aid business - Hearing aids sales of DKK 3,048m (+30% y-o-y) profited from a highly impressive organic growth of 26%, significantl...William Demant Holding is a holding company. Through its subsidiaries, Co develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. Co. focuses on four areas: Hearing Devices, Diagnostic Instruments, Hearing Implants and Personal Communication. Co.'s hearing devices include Oticon, Bernafon, Sonic, Phonic Ear, and FrontRow. Co.'s Hearing implant consist of Oticon Medical. Co.'s diagnostic instruments include Maico, Interacoustics, Amplivox, Grason-Stadler, MedRx, and Micromedical. Co.'s personal communication consists of Sennheiser Communications.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.